Skip to main content
Clinical Trials/TCTR20240405003
TCTR20240405003
Not Yet Recruiting
Phase 3

A Randomized controlled trial comparing pre-operative high volume lactated Ringer solution combined with human albumin versus standard volume lactated Ringer solution to prevent post-endoscopic retrograde cholangio-pancreatography pancreatitis

avamindradhiraj0 sites300 target enrollmentApril 5, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Post ERCP Pancreatitis
Sponsor
avamindradhiraj
Enrollment
300
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2024
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
avamindradhiraj

Eligibility Criteria

Inclusion Criteria

  • 1\. adult patient
  • 2\. Underwent ERCP from any cause

Exclusion Criteria

  • 1\. no informed consent
  • 2\. participant who has history or in active congestive heart failure (higher than New York Heart Association class 2\)
  • 3\. demonstrate sign of volume overload
  • 4\. severe comorbidity ( chronic kidney disease up to stage 3, advanced chronic obstructive pulmonary disease, and poorly controlled blood sugar)
  • 5\. history allergy of albumin solution

Outcomes

Primary Outcomes

Not specified

Similar Trials